ArticleOncoTargets and therapy2017

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway.

Yuehong Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.